Search - Finance Home - Yahoo! - Help

[ Latest Headlines | Market Overview | News Alerts ]

Headlines by Date Latest Mar 2 - Apr 25 Oct 27, 2011 - Mar 1, 2012 Jul 15 - Oct 26 May 25, 2011 - Jul 14, 2011

(all times are US Eastern)
Friday, May 25, 2012

• Europe stocks end week higher after choppy session - at MarketWatch - 5:07 pm
• Takeda chases emerging market sales with Brazil buy - at Reuters - 12:14 pm
• Glaxo Diabetes Drug Data Revealed Amid Hostile Takeover - at Bloomberg - 12:01 am

• Google, Vegas Strip Steak, Microsoft, ABC: Intellectual Property - at Bloomberg - 5:00 am
• Glaxo Avoids Market for Lemons by Acquiring Its Collaborators - at Bloomberg - 12:01 am

• GSK to drop Human Genome bid if "poison pill" stands - Reuters - 4:08 pm
• GSK says amends Human Genome tender offer conditions - at Reuters - 1:49 pm

• Fake drugs threaten gains made in war on malaria - at Reuters - 12:01 am

• Auxilium Pharmaceuticals, Inc. to discuss the agreement for the Testim® U.S. co-promotion with GlaxoSmithKline LLC - Conference call Call scheduled for 10:00 am ET today - CCBN - 3:00 pm
• Auxilium, Glaxo to co-promote Testim in US - AP - 2:44 pm
• UPDATE 1-Auxilium, GSK to co-promote testosterone gel in US - at Reuters - 12:59 pm
• Auxilium Pharmaceuticals, Inc. Raises Revenue Guidance And Reduces Net Loss Guidance For 2012 - PR Newswire - 12:00 pm
• Auxilium Pharmaceuticals, Inc. and GlaxoSmithKline LLC Enter Into a Co-Promotion Agreement for Testim® in the U.S. - PR Newswire - 12:00 pm

• GSK melanoma drug shows promise in early trial - at Reuters - 12:01 am

• Stopping Fake Drugs From Pakistan Is Too Late for Victims - at Bloomberg - 11:02 pm
• Human Genome board adopts 'poison pill' measure - AP - 3:38 pm
• Prestige Brands posts small fiscal 4Q loss - AP - 3:00 pm
• Human Genome in Talks With Potential Suitors - at Bloomberg - 2:11 pm
• Human Genome adopts rights as it wards off Glaxo - at Reuters - 12:15 pm
• RPT-Glaxo melanoma drug combo shows promise in small trial - at Reuters - 11:59 am

• Glaxo melanoma drug combo shows promise in small trial - at Reuters - 11:04 pm
• Glaxo’s Melanoma Cocktail Slows Cancer in Study - at Bloomberg - 11:00 pm
• GlaxoSmithKline closes on Theravance deal - AP - 3:26 pm
• GlaxoSmithKline Completes Transaction to Increase Its Ownership in Theravance - GlobeNewswire - 2:17 pm

• UPDATE 1-GSK pays 61 mln stg to take control of Cellzome - at Reuters - 11:01 am
• UK lawmakers urge action on medicine shortages - at Reuters - 8:00 am

• OncoMed Pharma files for IPO of up to $115 million - at Reuters - 5:26 pm
• UPDATE 1-OncoMed Pharma files for IPO of up to $115 mln - at Reuters - 5:21 pm
• Google’s Brin Makes Strides in Hunt for Parkinson’s Cure: Health - at Bloomberg - 5:00 am

• Gilead’s Pill Wins U.S. Panel Backing to Prevent HIV - at Bloomberg - 11:50 pm
• GSK starts $2.6 bln tender offer for Human Genome - at Reuters - 1:07 pm

• Risk of Unprotected Sex Debated in Gilead HIV Pill Review - at Bloomberg - 2:56 pm
• Top Headlines: Glaxo Turns Hostile on Human Genome - at Bloomberg - 12:15 pm
• GSK to launch $2.6 billion Human Genome tender offer - Reuters - 7:55 am
• Glaxo goes hostile with offer for Human Genome - at MarketWatch - 7:34 am
• Glaxo to Begin Hostile Offer for Human Genome Sciences - at Bloomberg - 7:07 am

• Gilead HIV Pill Shown Safe in Studies, FDA Staff Report Says - at Bloomberg - 2:00 pm

• Bonds Resurrected as Glaxo Leads Rising Sales - at Bloomberg - 5:06 pm

• UPDATE 1-Several arrested in US crackdown on drug thieves - at Reuters - 11:51 pm
• Dollar bond market lures European corporates - at Reuters - 8:56 pm
• GSK rejects idea of buying AstraZeneca - at Reuters - 6:56 pm

• New Issue-GlaxoSmithKline sells $5 bln notes in 3 parts - at Reuters - 10:34 pm
• GlaxoSmithKline Leads Borrowers Selling Most Debt Since March - at Bloomberg - 10:13 pm
• Biotech targets fight back as Big Pharma circles - Reuters - 6:16 pm
• ADR REPORT-Weak data again leads shares lower - at Reuters - 5:46 pm

• Estimated Dividend Yield Rankings of FTSE 100 Company - at Bloomberg - 12:55 pm
• INSIGHT-Cancer in Africa: Fighting a nameless enemy - at Reuters - 9:47 am

• Amarin up on Citi projections for cholesterol drug - AP - 7:12 pm
• Actelion Lung Drug Meets Main Goal in Pivotal Patient Study - at Bloomberg - 6:24 am
• Obesity-Linked Diabetes Tougher to Treat in Chindren - at Bloomberg - 5:00 am

• GSK bid undervalues Human Genome, investor says - Reuters - 4:44 pm
• Glaxo Bid Undervalues Human Genome Sciences, Sunday Times Says - at Bloomberg - 11:34 am

• EU plans to block fake drugs spark industry row - at Reuters - 2:50 pm

• FDA approves Votrient® for treatment of patients with certain types of advanced soft tissue sarcoma - PR Newswire - 11:54 pm
• UPDATE 1-US FDA approves Glaxo cancer drug Votrient - at Reuters - 10:56 pm
• Glaxo’s Votrient Gains U.S. Approval for Deadly Sarcomas - at Bloomberg - 10:55 pm
• U.S. Stock Options With Biggest Changes in Implied Volatility - at Bloomberg - 4:30 pm
• AstraZeneca CEO quits as drug sales tumble - Reuters - 1:59 pm
• FEATURE-Two new vaccines give Ghana hope for healthy growth - at Reuters - 10:20 am